Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden

Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden

Marie Linder,1 Anastasia Iliadou Nyman,2,3 Helle Kieler,1 Bengt Danielsson,2 Natalia Borg,2 Marcus Gry,2 Julius Collin2 1Centre for Pharmacoepidemiology, Karolinska Institutet, T2, Karolinska University Hospital, Stockholm, Sweden; 2The National Board of Health and Welfare, Stockholm, Sweden; 3Depar...

Full description

Bibliographic Details
Main Authors: Linder M, Iliadou Nyman A, Kieler H, Danielsson B, Borg N, Gry M, Collin J
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Clinical Epidemiology
Subjects:
anticoagulants
arrhythmia
epidemiology
safety
Online Access:https://www.dovepress.com/assessing-safety-of-direct-thrombin-inhibitors-direct-factor-xa-inhibi-peer-reviewed-article-CLEP

Internet

https://www.dovepress.com/assessing-safety-of-direct-thrombin-inhibitors-direct-factor-xa-inhibi-peer-reviewed-article-CLEP

Similar Items